Why the study?
Are peripheral venous concentrations of IrANP and catecholamines sensitive indicators of cardiac dysfunction in the general population?
Are peripheral venous concentrations of IrANP and catecholamines sensitive indicators of cardiac dysfunction in the general population?
Peripheral venous IrANP is more closely related to cardiac function than catecholamines but is not a sensitive marker for early cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
IrANP and noradrenaline lack sensitivity for early cardiac dysfunction; leaves open their biomarker role in severe dyspnoea only.
Caidahl et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: